BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26947089)

  • 1. [Novelties in diagnostics and treatment of prostate cancer].
    Riesz P; Nyírádi P
    Orv Hetil; 2016 Mar; 157(11):410-4. PubMed ID: 26947089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Urakami S; Masuda H; Numao N; Ishikawa Y; Kohno A; Fukui I
    Jpn J Clin Oncol; 2012 Jun; 42(6):541-7. PubMed ID: 22457326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
    Wiegel T; Bartkowiak D; Bottke D; Bronner C; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Stöckle M; Rübe C; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hofmann R; Engenhart-Cabillic R; Hinke A; Hinkelbein W; Miller K
    Eur Urol; 2014 Aug; 66(2):243-50. PubMed ID: 24680359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
    Haines IE; Gabor Miklos GL
    J Natl Cancer Inst; 2013 Oct; 105(20):1534-9. PubMed ID: 24092918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.
    Hong SK; Sternberg IA; Keren Paz GE; Kim PH; Touijer KA; Scardino PT; Eastham JA
    Eur Urol; 2014 Aug; 66(2):214-9. PubMed ID: 23954083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 18F-choline positron emission tomography/CT in high-risk prostate cancer: a case of solitary adrenal metastasis.
    Matrone F; Sivolella S; Bellavita R; Casciola L; Cristallini EG; Aristei C
    Tumori; 2015 Mar; 101(1):e21-3. PubMed ID: 25702663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
    Carroll PH; Mohler JL
    J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
    Wieder JA; Soloway MS
    J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Hammerer P
    Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of surgery in high-risk tumours of the prostate].
    Soulié M; Rozet F; Hennequin C; Salomon L;
    Cancer Radiother; 2010 Oct; 14(6-7):493-9. PubMed ID: 20727805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present and future management of prostate cancer.
    de Vere White R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):121-5. PubMed ID: 10803316
    [No Abstract]   [Full Text] [Related]  

  • 13. RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
    Carlsson S; Roobol MJ; Schröder FH; Hugosson J; Auvinen A
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24771874
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
    Walsh PC
    J Natl Cancer Inst; 2014 Feb; 106(2):djt432. PubMed ID: 24399847
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging of prostate cancer.
    Akin O; Hricak H
    Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Bartkowiak D
    Aktuelle Urol; 2016 Feb; 47(1):22-4. PubMed ID: 26903117
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic challenges of clonal heterogeneity in prostate cancer.
    Haffner MC; De Marzo AM; Yegnasubramanian S; Epstein JI; Carter HB
    J Clin Oncol; 2015 Mar; 33(7):e38-40. PubMed ID: 24638011
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer screening: biases and the need for consensus.
    Brawley OW
    J Natl Cancer Inst; 2013 Oct; 105(20):1522-4. PubMed ID: 24092919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment of early prostate cancer].
    Kaprin AD; Khalil Farzat M; Gafanov RA; Kostin AA
    Vopr Onkol; 2009; 55(3):382-5. PubMed ID: 19670743
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.